首页 › 基金 › WorthPointe, LLC › IBD
WorthPointe, LLC 对 IBD 的持仓历史
NORTHERN LTS FD TR IV
WorthPointe, LLC 在 Q2 2026 的 13F 申报中披露持有 IBD(NORTHERN LTS FD TR IV)154,171 股,市值约 US$3.7M,约占其申报组合的 0.92%,在其申报持仓中市值排名第 23 位。 WorthPointe, LLC 最近 12 个申报季度中有 5 个季度披露了 IBD 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
WorthPointe, LLC 对 IBD 的持仓演变
WorthPointe, LLC 于 Q3 2023 首次披露 IBD 持仓:41,095 股(约 US$930K)。 该持仓在 Q4 2025 达到峰值 312,296 股,市值约 US$7.6M。 在 5 次申报中,WorthPointe, LLC 1 次增持、2 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 154,171 股、市值约 US$3.7M,环比减持 -52,796 股。。 持仓曾出现大幅变动:Q4 2023 增持约 168% (随后一个季度股价基本持平)、Q1 2026 减持约 34% (随后一个季度股价基本持平)、Q2 2026 减持约 26% (随后一个季度股价下跌 3%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 41.09K | $930.39K | 新进 |
| Q4 2023 | 110.14K | $2.60M | 增持 |
| Q4 2025 | 312.30K | $7.56M | 新进 |
| Q1 2026 | 206.97K | $4.94M | 减持 |
| Q2 2026 | 154.17K | $3.66M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IBD 与 13F 数据
IBD(NORTHERN LTS FD TR IV)的行业分类暂缺。我们追踪的基金中还有 30 只申报持有 IBD,申报仓位最大的包括:Inspire Advisors, LLC (US$97.5M), Faithward Advisors, LLC (US$40.8M), CREATIVE FINANCIAL DESIGNS INC /ADV (US$23.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IBD 的基金
- Inspire Advisors, LLC 4.10M 股 · $97.52M · Q2 2026
- Faithward Advisors, LLC 1.72M 股 · $40.79M · Q2 2026
- CREATIVE FINANCIAL DESIGNS INC /ADV 968.28K 股 · $23.02M · Q2 2026
- Bare Financial Services, Inc 795.09K 股 · $18.90M · Q2 2026
- Inspire Investing, LLC 768.59K 股 · $18.27M · Q2 2026
- OneAscent Financial Services LLC 548.88K 股 · $13.05M · Q2 2026
- Plan A Wealth LLC 395.82K 股 · $9.10M · Q3 2026
- PAX Financial Group, LLC 348.67K 股 · $8.29M · Q2 2026
- Legacy Wealth Asset Management, LLC 256.14K 股 · $5.89M · Q3 2026
- LVZ, Inc. 197.62K 股 · $4.70M · Q2 2026
- Range Financial Group LLC 152.72K 股 · $3.63M · Q2 2026
- OneAscent Investment Solutions LLC 147.94K 股 · $3.52M · Q2 2026
更多关于 WorthPointe, LLC
常见问题
How long has WorthPointe, LLC held IBD?
WorthPointe, LLC has disclosed IBD holdings in 5 of the last 12 reported quarters, going back to Q3 2023.
What is WorthPointe, LLC's current position in IBD?
As of Q2 2026, WorthPointe, LLC holds 154.17K shares of IBD (NORTHERN LTS FD TR IV), valued at $3.66M, representing 0.92% of its reported portfolio and ranking #23.
Has WorthPointe, LLC been buying or selling IBD?
In the latest 13F filing (Q2 2026), WorthPointe, LLC reduced its position in IBD. The position peaked in Q4 2025 at 312.30K shares.
Which other funds hold IBD?
Other major institutional holders of IBD include Inspire Advisors, LLC, Faithward Advisors, LLC, CREATIVE FINANCIAL DESIGNS INC /ADV, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.